Actually Trey,
This year at ASH there was lots of renewed interest in low dose
interferon and using it in combination with other drugs.
There is also new work on the fact that Peg IFN seems to lessen the
side effects. Anyway, some of the biggest names in CML were quite
interested and vowed to s
The IRIS Study has shown that Gleevec is far superior to the previous
drugs. Even if people initially responded to Interferon, Ara-C, and
Hydroxyurea, these responses were not as deep and durable as with
Gleevec, so long term survival rates were poor when compared to the
95% overall survival rate
2 matches
Mail list logo
